APA (7th ed.) Citation

Guillen, S. M., García, J. E. L., Berenguer, J. B., Sesmero, J. M. M., Gomis, S. C., Graefenhain, R., . . . Garcia, F. J. P. Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain. Elsevier.

Chicago Style (17th ed.) Citation

Guillen, Santiago Moreno, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, and Francisco Javier Parrondo Garcia. Cost-utility Analysis of the Fixed-dose Combination of Dolutegravir/abacavir/lamivudine as Initial Treatment of HIV+ Patients in Spain. Elsevier.

MLA (9th ed.) Citation

Guillen, Santiago Moreno, et al. Cost-utility Analysis of the Fixed-dose Combination of Dolutegravir/abacavir/lamivudine as Initial Treatment of HIV+ Patients in Spain. Elsevier.